Delcath Systems, Inc. (NASDAQ: DCTH) Stock Competitors & Peer Comparison
See DCTH's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Devices Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for DCTH and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| DCTH | $14.93 | +3.04% | 518.4M | 1494.00 | $0.01 | N/A |
| ABT | $109.93 | -3.23% | 190.3B | 21.10 | $5.21 | +2.28% |
| BSX-PA | $122.18 | +2.37% | 175.4B | 230.53 | $0.53 | N/A |
| MDT | $101.80 | -2.90% | 130.2B | 18.41 | $5.53 | +2.81% |
| SYK | $325.87 | -2.75% | 124.1B | 24.34 | $13.39 | +1.09% |
| BSX | $42.75 | -4.23% | 62B | 13.79 | $3.10 | N/A |
| EW | $102.14 | +1.31% | 58.9B | 37.82 | $2.70 | N/A |
| GEHC | $82.38 | -1.64% | 37.2B | 16.81 | $4.90 | +0.18% |
| PHG | $30.35 | -0.52% | 29.7B | 17.34 | $1.75 | +3.27% |
| DXCM | $79.41 | -5.98% | 29.6B | 31.14 | $2.55 | N/A |
Stock Comparison
Abbott Laboratories (NYSE: ABT)
DCTH vs ABT Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, ABT has a market cap of 190.3B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while ABT trades at $109.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas ABT's P/E ratio is 21.10. In terms of profitability, DCTH's ROE is +0.00%, compared to ABT's ROE of +0.09%. Regarding short-term risk, DCTH is more volatile compared to ABT. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ABT's competition here
Boston Scientific Corporation (NYSE: BSX-PA)
DCTH vs BSX-PA Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, BSX-PA has a market cap of 175.4B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while BSX-PA trades at $122.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas BSX-PA's P/E ratio is 230.53. In terms of profitability, DCTH's ROE is +0.00%, compared to BSX-PA's ROE of +0.14%. Regarding short-term risk, DCTH is more volatile compared to BSX-PA. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check BSX-PA's competition here
Medtronic Plc (NYSE: MDT)
DCTH vs MDT Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, MDT has a market cap of 130.2B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while MDT trades at $101.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas MDT's P/E ratio is 18.41. In terms of profitability, DCTH's ROE is +0.00%, compared to MDT's ROE of +0.11%. Regarding short-term risk, DCTH is more volatile compared to MDT. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check MDT's competition here
Stryker Corporation (NYSE: SYK)
DCTH vs SYK Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, SYK has a market cap of 124.1B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while SYK trades at $325.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas SYK's P/E ratio is 24.34. In terms of profitability, DCTH's ROE is +0.00%, compared to SYK's ROE of +0.16%. Regarding short-term risk, DCTH is more volatile compared to SYK. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SYK's competition here
Boston Scientific Corporation (NYSE: BSX)
DCTH vs BSX Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, BSX has a market cap of 62B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while BSX trades at $42.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas BSX's P/E ratio is 13.79. In terms of profitability, DCTH's ROE is +0.00%, compared to BSX's ROE of +0.14%. Regarding short-term risk, DCTH is more volatile compared to BSX. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check BSX's competition here
Edwards Lifesciences Corporation (NYSE: EW)
DCTH vs EW Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, EW has a market cap of 58.9B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while EW trades at $102.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas EW's P/E ratio is 37.82. In terms of profitability, DCTH's ROE is +0.00%, compared to EW's ROE of +0.10%. Regarding short-term risk, DCTH is more volatile compared to EW. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check EW's competition here
GE HealthCare Technologies Inc. (NASDAQ: GEHC)
DCTH vs GEHC Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, GEHC has a market cap of 37.2B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while GEHC trades at $82.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas GEHC's P/E ratio is 16.81. In terms of profitability, DCTH's ROE is +0.00%, compared to GEHC's ROE of +0.16%. Regarding short-term risk, DCTH is more volatile compared to GEHC. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check GEHC's competition here
Koninklijke Philips N.V. (NYSE: PHG)
DCTH vs PHG Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, PHG has a market cap of 29.7B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while PHG trades at $30.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas PHG's P/E ratio is 17.34. In terms of profitability, DCTH's ROE is +0.00%, compared to PHG's ROE of +0.08%. Regarding short-term risk, DCTH is more volatile compared to PHG. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check PHG's competition here
DexCom, Inc. (NASDAQ: DXCM)
DCTH vs DXCM Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, DXCM has a market cap of 29.6B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while DXCM trades at $79.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas DXCM's P/E ratio is 31.14. In terms of profitability, DCTH's ROE is +0.00%, compared to DXCM's ROE of +0.37%. Regarding short-term risk, DCTH is less volatile compared to DXCM. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check DXCM's competition here
Zimmer Biomet Holdings, Inc. (NYSE: ZBH)
DCTH vs ZBH Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, ZBH has a market cap of 20.1B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while ZBH trades at $105.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas ZBH's P/E ratio is 12.45. In terms of profitability, DCTH's ROE is +0.00%, compared to ZBH's ROE of +0.06%. Regarding short-term risk, DCTH is more volatile compared to ZBH. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ZBH's competition here
Abiomed, Inc. (NASDAQ: ABMD)
DCTH vs ABMD Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, ABMD has a market cap of 17.2B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while ABMD trades at $381.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas ABMD's P/E ratio is 65.36. In terms of profitability, DCTH's ROE is +0.00%, compared to ABMD's ROE of +0.10%. Regarding short-term risk, DCTH is more volatile compared to ABMD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ABMD's competition here
Glaukos Corporation (NYSE: GKOS)
DCTH vs GKOS Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, GKOS has a market cap of 13.3B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while GKOS trades at $224.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas GKOS's P/E ratio is -260.83. In terms of profitability, DCTH's ROE is +0.00%, compared to GKOS's ROE of -0.25%. Regarding short-term risk, DCTH is less volatile compared to GKOS. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check GKOS's competition here
Smith & Nephew plc (NYSE: SNN)
DCTH vs SNN Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, SNN has a market cap of 13.1B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while SNN trades at $31.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas SNN's P/E ratio is 21.03. In terms of profitability, DCTH's ROE is +0.00%, compared to SNN's ROE of +0.12%. Regarding short-term risk, DCTH is more volatile compared to SNN. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SNN's competition here
Penumbra, Inc. (NYSE: PEN)
DCTH vs PEN Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, PEN has a market cap of 12.6B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while PEN trades at $319.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas PEN's P/E ratio is 83.37. In terms of profitability, DCTH's ROE is +0.00%, compared to PEN's ROE of +0.10%. Regarding short-term risk, DCTH is more volatile compared to PEN. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check PEN's competition here
ShockWave Medical, Inc. (NASDAQ: SWAV)
DCTH vs SWAV Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, SWAV has a market cap of 12.6B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while SWAV trades at $334.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas SWAV's P/E ratio is 78.76. In terms of profitability, DCTH's ROE is +0.00%, compared to SWAV's ROE of +0.25%. Regarding short-term risk, DCTH is more volatile compared to SWAV. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SWAV's competition here
Align Technology, Inc. (NASDAQ: ALGN)
DCTH vs ALGN Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, ALGN has a market cap of 11.8B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while ALGN trades at $166.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas ALGN's P/E ratio is 15.14. In terms of profitability, DCTH's ROE is +0.00%, compared to ALGN's ROE of +0.12%. Regarding short-term risk, DCTH is less volatile compared to ALGN. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check ALGN's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO)
DCTH vs BIO Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, BIO has a market cap of 10.2B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while BIO trades at $381.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas BIO's P/E ratio is 41.12. In terms of profitability, DCTH's ROE is +0.00%, compared to BIO's ROE of +0.14%. Regarding short-term risk, DCTH is less volatile compared to BIO. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check BIO's competition here
Insulet Corp. (NASDAQ: PODD)
DCTH vs PODD Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, PODD has a market cap of 10.2B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while PODD trades at $146.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas PODD's P/E ratio is 24.96. In terms of profitability, DCTH's ROE is +0.00%, compared to PODD's ROE of +0.29%. Regarding short-term risk, DCTH is less volatile compared to PODD. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check PODD's competition here
Bio-Rad Laboratories, Inc. (NYSE: BIO-B)
DCTH vs BIO-B Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, BIO-B has a market cap of 9.9B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while BIO-B trades at $374.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas BIO-B's P/E ratio is -65.97. In terms of profitability, DCTH's ROE is +0.00%, compared to BIO-B's ROE of +0.14%. Regarding short-term risk, DCTH is less volatile compared to BIO-B. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check BIO-B's competition here
Globus Medical, Inc. (NYSE: GMED)
DCTH vs GMED Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, GMED has a market cap of 9.5B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while GMED trades at $71.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas GMED's P/E ratio is 16.00. In terms of profitability, DCTH's ROE is +0.00%, compared to GMED's ROE of +0.12%. Regarding short-term risk, DCTH is less volatile compared to GMED. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check GMED's competition here
Masimo Corporation (NASDAQ: MASI)
DCTH vs MASI Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, MASI has a market cap of 9.4B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while MASI trades at $179.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas MASI's P/E ratio is 44.43. In terms of profitability, DCTH's ROE is +0.00%, compared to MASI's ROE of +0.09%. Regarding short-term risk, DCTH is more volatile compared to MASI. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check MASI's competition here
Bruker Corporation (NASDAQ: BRKR)
DCTH vs BRKR Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, BRKR has a market cap of 9.3B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while BRKR trades at $61.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas BRKR's P/E ratio is 30.81. In terms of profitability, DCTH's ROE is +0.00%, compared to BRKR's ROE of -0.05%. Regarding short-term risk, DCTH is less volatile compared to BRKR. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check BRKR's competition here
Bruker Corporation (NASDAQ: BRKRP)
DCTH vs BRKRP Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, BRKRP has a market cap of 9.3B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while BRKRP trades at $446.63.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas BRKRP's P/E ratio is 244.34. In terms of profitability, DCTH's ROE is +0.00%, compared to BRKRP's ROE of -0.05%. Regarding short-term risk, DCTH is more volatile compared to BRKRP. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check BRKRP's competition here
Haemonetics Corporation (NYSE: HAE)
DCTH vs HAE Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, HAE has a market cap of 5.5B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while HAE trades at $119.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas HAE's P/E ratio is 23.93. In terms of profitability, DCTH's ROE is +0.00%, compared to HAE's ROE of +0.12%. Regarding short-term risk, DCTH is less volatile compared to HAE. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check HAE's competition here
LivaNova PLC (NASDAQ: LIVN)
DCTH vs LIVN Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, LIVN has a market cap of 4.9B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while LIVN trades at $89.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas LIVN's P/E ratio is 21.37. In terms of profitability, DCTH's ROE is +0.00%, compared to LIVN's ROE of +0.15%. Regarding short-term risk, DCTH is more volatile compared to LIVN. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check LIVN's competition here
Inari Medical, Inc. (NASDAQ: NARI)
DCTH vs NARI Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, NARI has a market cap of 4.7B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while NARI trades at $79.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas NARI's P/E ratio is -59.24. In terms of profitability, DCTH's ROE is +0.00%, compared to NARI's ROE of -0.00%. Regarding short-term risk, DCTH is more volatile compared to NARI. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check NARI's competition here
Integer Holdings Corporation (NYSE: ITGR)
DCTH vs ITGR Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, ITGR has a market cap of 4.3B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while ITGR trades at $126.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas ITGR's P/E ratio is 19.94. In terms of profitability, DCTH's ROE is +0.00%, compared to ITGR's ROE of +0.06%. Regarding short-term risk, DCTH is more volatile compared to ITGR. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ITGR's competition here
TransMedics Group, Inc. (NASDAQ: TMDX)
DCTH vs TMDX Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, TMDX has a market cap of 3.1B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while TMDX trades at $88.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas TMDX's P/E ratio is 44.77. In terms of profitability, DCTH's ROE is +0.00%, compared to TMDX's ROE of +0.28%. Regarding short-term risk, DCTH is less volatile compared to TMDX. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check TMDX's competition here
AxoGen, Inc. (NASDAQ: AXGN)
DCTH vs AXGN Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, AXGN has a market cap of 3B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while AXGN trades at $50.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas AXGN's P/E ratio is 131.53. In terms of profitability, DCTH's ROE is +0.00%, compared to AXGN's ROE of -0.11%. Regarding short-term risk, DCTH is less volatile compared to AXGN. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check AXGN's competition here
iRhythm Technologies, Inc. (NASDAQ: IRTC)
DCTH vs IRTC Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, IRTC has a market cap of 3B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while IRTC trades at $90.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas IRTC's P/E ratio is -209.53. In terms of profitability, DCTH's ROE is +0.00%, compared to IRTC's ROE of -0.23%. Regarding short-term risk, DCTH is less volatile compared to IRTC. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check IRTC's competition here
Neogen Corporation (NASDAQ: NEOG)
DCTH vs NEOG Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, NEOG has a market cap of 2.6B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while NEOG trades at $11.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas NEOG's P/E ratio is 42.00. In terms of profitability, DCTH's ROE is +0.00%, compared to NEOG's ROE of -0.03%. Regarding short-term risk, DCTH is less volatile compared to NEOG. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check NEOG's competition here
UFP Technologies, Inc. (NASDAQ: UFPT)
DCTH vs UFPT Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, UFPT has a market cap of 2.3B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while UFPT trades at $303.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas UFPT's P/E ratio is 30.94. In terms of profitability, DCTH's ROE is +0.00%, compared to UFPT's ROE of +0.17%. Regarding short-term risk, DCTH is less volatile compared to UFPT. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check UFPT's competition here
NuVasive, Inc. (NASDAQ: NUVA)
DCTH vs NUVA Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, NUVA has a market cap of 2.1B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while NUVA trades at $39.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas NUVA's P/E ratio is 75.00. In terms of profitability, DCTH's ROE is +0.00%, compared to NUVA's ROE of +0.05%. Regarding short-term risk, DCTH is more volatile compared to NUVA. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check NUVA's competition here
Establishment Labs Holdings Inc. (NASDAQ: ESTA)
DCTH vs ESTA Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, ESTA has a market cap of 2B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while ESTA trades at $67.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas ESTA's P/E ratio is -53.24. In terms of profitability, DCTH's ROE is +0.00%, compared to ESTA's ROE of -2.04%. Regarding short-term risk, DCTH is less volatile compared to ESTA. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check ESTA's competition here
Inspire Medical Systems, Inc. (NYSE: INSP)
DCTH vs INSP Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, INSP has a market cap of 1.9B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while INSP trades at $63.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas INSP's P/E ratio is 28.18. In terms of profitability, DCTH's ROE is +0.00%, compared to INSP's ROE of +0.12%. Regarding short-term risk, DCTH is less volatile compared to INSP. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check INSP's competition here
Butterfly Network, Inc. (NYSE: BFLY)
DCTH vs BFLY Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, BFLY has a market cap of 1.7B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while BFLY trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas BFLY's P/E ratio is -26.52. In terms of profitability, DCTH's ROE is +0.00%, compared to BFLY's ROE of -0.28%. Regarding short-term risk, DCTH is less volatile compared to BFLY. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check BFLY's competition here
Enovis Corporation (NYSE: ENOV)
DCTH vs ENOV Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, ENOV has a market cap of 1.6B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while ENOV trades at $27.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas ENOV's P/E ratio is 7.77. In terms of profitability, DCTH's ROE is +0.00%, compared to ENOV's ROE of -0.36%. Regarding short-term risk, DCTH is less volatile compared to ENOV. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check ENOV's competition here
Novocure Ltd (NASDAQ: NVCR)
DCTH vs NVCR Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, NVCR has a market cap of 1.6B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while NVCR trades at $13.28.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas NVCR's P/E ratio is -12.52. In terms of profitability, DCTH's ROE is +0.00%, compared to NVCR's ROE of -0.36%. Regarding short-term risk, DCTH is less volatile compared to NVCR. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check NVCR's competition here
CONMED Corporation (NYSE: CNMD)
DCTH vs CNMD Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, CNMD has a market cap of 1.5B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while CNMD trades at $51.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas CNMD's P/E ratio is 11.32. In terms of profitability, DCTH's ROE is +0.00%, compared to CNMD's ROE of +0.07%. Regarding short-term risk, DCTH is more volatile compared to CNMD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check CNMD's competition here
Heska Corporation (NASDAQ: HSKA)
DCTH vs HSKA Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, HSKA has a market cap of 1.3B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while HSKA trades at $119.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas HSKA's P/E ratio is -62.49. In terms of profitability, DCTH's ROE is +0.00%, compared to HSKA's ROE of -0.04%. Regarding short-term risk, DCTH is more volatile compared to HSKA. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check HSKA's competition here
Lumexa Imaging Holdings, Inc. Common Stock (NASDAQ: LMRI)
DCTH vs LMRI Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, LMRI has a market cap of 1.3B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while LMRI trades at $13.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas LMRI's P/E ratio is -26.07. In terms of profitability, DCTH's ROE is +0.00%, compared to LMRI's ROE of -0.06%. Regarding short-term risk, DCTH is less volatile compared to LMRI. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check LMRI's competition here
Tandem Diabetes Care, Inc. (NASDAQ: TNDM)
DCTH vs TNDM Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, TNDM has a market cap of 1.2B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while TNDM trades at $16.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas TNDM's P/E ratio is -18.18. In terms of profitability, DCTH's ROE is +0.00%, compared to TNDM's ROE of -0.36%. Regarding short-term risk, DCTH is less volatile compared to TNDM. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check TNDM's competition here
PROCEPT BioRobotics Corporation (NASDAQ: PRCT)
DCTH vs PRCT Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, PRCT has a market cap of 1.2B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while PRCT trades at $20.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas PRCT's P/E ratio is -10.62. In terms of profitability, DCTH's ROE is +0.00%, compared to PRCT's ROE of -0.33%. Regarding short-term risk, DCTH is less volatile compared to PRCT. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check PRCT's competition here
Avanos Medical, Inc. (NYSE: AVNS)
DCTH vs AVNS Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, AVNS has a market cap of 1.2B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while AVNS trades at $24.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas AVNS's P/E ratio is 27.77. In terms of profitability, DCTH's ROE is +0.00%, compared to AVNS's ROE of -0.09%. Regarding short-term risk, DCTH is more volatile compared to AVNS. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check AVNS's competition here
Alphatec Holdings, Inc. (NASDAQ: ATEC)
DCTH vs ATEC Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, ATEC has a market cap of 1.2B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while ATEC trades at $7.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas ATEC's P/E ratio is -13.21. In terms of profitability, DCTH's ROE is +0.00%, compared to ATEC's ROE of -5.47%. Regarding short-term risk, DCTH is less volatile compared to ATEC. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check ATEC's competition here
Silk Road Medical, Inc (NASDAQ: SILK)
DCTH vs SILK Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, SILK has a market cap of 1.1B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while SILK trades at $27.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas SILK's P/E ratio is -18.96. In terms of profitability, DCTH's ROE is +0.00%, compared to SILK's ROE of -0.35%. Regarding short-term risk, DCTH is more volatile compared to SILK. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SILK's competition here
Paragon 28, Inc. (NYSE: FNA)
DCTH vs FNA Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, FNA has a market cap of 1.1B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while FNA trades at $13.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas FNA's P/E ratio is -19.83. In terms of profitability, DCTH's ROE is +0.00%, compared to FNA's ROE of -0.35%. Regarding short-term risk, DCTH is more volatile compared to FNA. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check FNA's competition here
IRadimed Corporation (NASDAQ: IRMD)
DCTH vs IRMD Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, IRMD has a market cap of 1.1B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while IRMD trades at $86.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas IRMD's P/E ratio is 43.16. In terms of profitability, DCTH's ROE is +0.00%, compared to IRMD's ROE of +0.24%. Regarding short-term risk, DCTH is more volatile compared to IRMD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check IRMD's competition here
SI-BONE, Inc. (NASDAQ: SIBN)
DCTH vs SIBN Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, SIBN has a market cap of 1.1B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while SIBN trades at $24.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas SIBN's P/E ratio is -71.29. In terms of profitability, DCTH's ROE is +0.00%, compared to SIBN's ROE of -0.08%. Regarding short-term risk, DCTH is less volatile compared to SIBN. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check SIBN's competition here
Integra LifeSciences Holdings Corporation (NASDAQ: IART)
DCTH vs IART Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, IART has a market cap of 1B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while IART trades at $13.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas IART's P/E ratio is 5.69. In terms of profitability, DCTH's ROE is +0.00%, compared to IART's ROE of +0.01%. Regarding short-term risk, DCTH is less volatile compared to IART. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check IART's competition here
CeriBell, Inc. (NASDAQ: CBLL)
DCTH vs CBLL Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, CBLL has a market cap of 1B. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while CBLL trades at $26.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas CBLL's P/E ratio is -15.12. In terms of profitability, DCTH's ROE is +0.00%, compared to CBLL's ROE of -0.55%. Regarding short-term risk, DCTH is less volatile compared to CBLL. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check CBLL's competition here
AdaptHealth Corp. (NASDAQ: AHCO)
DCTH vs AHCO Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, AHCO has a market cap of 998.7M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while AHCO trades at $7.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas AHCO's P/E ratio is 14.95. In terms of profitability, DCTH's ROE is +0.00%, compared to AHCO's ROE of -0.29%. Regarding short-term risk, DCTH is less volatile compared to AHCO. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check AHCO's competition here
Artivion, Inc. (NYSE: AORT)
DCTH vs AORT Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, AORT has a market cap of 985.1M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while AORT trades at $20.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas AORT's P/E ratio is 33.67. In terms of profitability, DCTH's ROE is +0.00%, compared to AORT's ROE of -0.04%. Regarding short-term risk, DCTH is less volatile compared to AORT. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check AORT's competition here
Picard Medical, Inc. (AMEX: PMI)
DCTH vs PMI Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, PMI has a market cap of 877.7M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while PMI trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas PMI's P/E ratio is -7.12. In terms of profitability, DCTH's ROE is +0.00%, compared to PMI's ROE of -9.31%. Regarding short-term risk, DCTH is less volatile compared to PMI. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check PMI's competition here
Cardiovascular Systems, Inc. (NASDAQ: CSII)
DCTH vs CSII Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, CSII has a market cap of 844M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while CSII trades at $20.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas CSII's P/E ratio is -20.83. In terms of profitability, DCTH's ROE is +0.00%, compared to CSII's ROE of -0.14%. Regarding short-term risk, DCTH is more volatile compared to CSII. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check CSII's competition here
OrthoPediatrics Corp. (NASDAQ: KIDS)
DCTH vs KIDS Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, KIDS has a market cap of 829.5M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while KIDS trades at $31.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas KIDS's P/E ratio is -23.71. In terms of profitability, DCTH's ROE is +0.00%, compared to KIDS's ROE of -0.10%. Regarding short-term risk, DCTH is more volatile compared to KIDS. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check KIDS's competition here
Varex Imaging Corporation (NASDAQ: VREX)
DCTH vs VREX Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, VREX has a market cap of 783.4M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while VREX trades at $18.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas VREX's P/E ratio is 19.42. In terms of profitability, DCTH's ROE is +0.00%, compared to VREX's ROE of +0.05%. Regarding short-term risk, DCTH is more volatile compared to VREX. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check VREX's competition here
InMode Ltd. (NASDAQ: INMD)
DCTH vs INMD Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, INMD has a market cap of 767.6M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while INMD trades at $13.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas INMD's P/E ratio is 9.26. In terms of profitability, DCTH's ROE is +0.00%, compared to INMD's ROE of +0.12%. Regarding short-term risk, DCTH is more volatile compared to INMD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check INMD's competition here
Cytek Biosciences, Inc. (NASDAQ: CTKB)
DCTH vs CTKB Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, CTKB has a market cap of 760.4M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while CTKB trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas CTKB's P/E ratio is -30.99. In terms of profitability, DCTH's ROE is +0.00%, compared to CTKB's ROE of -0.25%. Regarding short-term risk, DCTH is less volatile compared to CTKB. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check CTKB's competition here
Bioventus Inc. (NASDAQ: BVS)
DCTH vs BVS Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, BVS has a market cap of 725.1M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while BVS trades at $10.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas BVS's P/E ratio is 13.93. In terms of profitability, DCTH's ROE is +0.00%, compared to BVS's ROE of +0.27%. Regarding short-term risk, DCTH is less volatile compared to BVS. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check BVS's competition here
Beta Bionics, Inc. (NASDAQ: BBNX)
DCTH vs BBNX Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, BBNX has a market cap of 706.8M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while BBNX trades at $15.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas BBNX's P/E ratio is -8.54. In terms of profitability, DCTH's ROE is +0.00%, compared to BBNX's ROE of -0.27%. Regarding short-term risk, DCTH is less volatile compared to BBNX. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check BBNX's competition here
Pacific Biosciences of California, Inc. (NASDAQ: PACB)
DCTH vs PACB Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, PACB has a market cap of 700.9M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while PACB trades at $2.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas PACB's P/E ratio is -5.50. In terms of profitability, DCTH's ROE is +0.00%, compared to PACB's ROE of +6.04%. Regarding short-term risk, DCTH is less volatile compared to PACB. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check PACB's competition here
Surmodics, Inc. (NASDAQ: SRDX)
DCTH vs SRDX Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, SRDX has a market cap of 614.5M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while SRDX trades at $42.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas SRDX's P/E ratio is -34.66. In terms of profitability, DCTH's ROE is +0.00%, compared to SRDX's ROE of -0.10%. Regarding short-term risk, DCTH is more volatile compared to SRDX. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SRDX's competition here
Tactile Systems Technology, Inc. (NASDAQ: TCMD)
DCTH vs TCMD Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, TCMD has a market cap of 583.1M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while TCMD trades at $26.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas TCMD's P/E ratio is 24.10. In terms of profitability, DCTH's ROE is +0.00%, compared to TCMD's ROE of +0.11%. Regarding short-term risk, DCTH is more volatile compared to TCMD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check TCMD's competition here
Apollo Endosurgery, Inc. (NASDAQ: APEN)
DCTH vs APEN Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, APEN has a market cap of 579.7M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while APEN trades at $10.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas APEN's P/E ratio is -9.43. In terms of profitability, DCTH's ROE is +0.00%, compared to APEN's ROE of -0.85%. Regarding short-term risk, DCTH is more volatile compared to APEN. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check APEN's competition here
Sight Sciences, Inc. (NASDAQ: SGHT)
DCTH vs SGHT Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, SGHT has a market cap of 556.4M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while SGHT trades at $10.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas SGHT's P/E ratio is -18.04. In terms of profitability, DCTH's ROE is +0.00%, compared to SGHT's ROE of -0.52%. Regarding short-term risk, DCTH is less volatile compared to SGHT. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check SGHT's competition here
Anteris Technologies Global Corp. (NASDAQ: AVR)
DCTH vs AVR Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, AVR has a market cap of 554.1M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while AVR trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas AVR's P/E ratio is -2.93. In terms of profitability, DCTH's ROE is +0.00%, compared to AVR's ROE of -0.78%. Regarding short-term risk, DCTH is less volatile compared to AVR. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check AVR's competition here
ZimVie Inc. (NASDAQ: ZIMV)
DCTH vs ZIMV Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, ZIMV has a market cap of 535.6M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while ZIMV trades at $18.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas ZIMV's P/E ratio is -27.52. In terms of profitability, DCTH's ROE is +0.00%, compared to ZIMV's ROE of -0.07%. Regarding short-term risk, DCTH is more volatile compared to ZIMV. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ZIMV's competition here
Senseonics Holdings, Inc. (NASDAQ: SENS)
DCTH vs SENS Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, SENS has a market cap of 453.7M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while SENS trades at $8.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas SENS's P/E ratio is -3.85. In terms of profitability, DCTH's ROE is +0.00%, compared to SENS's ROE of -1.66%. Regarding short-term risk, DCTH is less volatile compared to SENS. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check SENS's competition here
SS Innovations International, Inc. (NASDAQ: SSII)
DCTH vs SSII Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, SSII has a market cap of 430M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while SSII trades at $2.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas SSII's P/E ratio is -35.75. In terms of profitability, DCTH's ROE is +0.00%, compared to SSII's ROE of -0.27%. Regarding short-term risk, DCTH is less volatile compared to SSII. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check SSII's competition here
NeuroPace, Inc. (NASDAQ: NPCE)
DCTH vs NPCE Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, NPCE has a market cap of 428.4M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while NPCE trades at $12.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas NPCE's P/E ratio is -21.89. In terms of profitability, DCTH's ROE is +0.00%, compared to NPCE's ROE of -1.20%. Regarding short-term risk, DCTH is less volatile compared to NPCE. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check NPCE's competition here
Avita Medical Inc. (NASDAQ: RCEL)
DCTH vs RCEL Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, RCEL has a market cap of 412.4M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while RCEL trades at $16.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas RCEL's P/E ratio is -11.53. In terms of profitability, DCTH's ROE is +0.00%, compared to RCEL's ROE of +1.46%. Regarding short-term risk, DCTH is less volatile compared to RCEL. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check RCEL's competition here
Cerus Corporation (NASDAQ: CERS)
DCTH vs CERS Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, CERS has a market cap of 406.9M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while CERS trades at $2.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas CERS's P/E ratio is -66.94. In terms of profitability, DCTH's ROE is +0.00%, compared to CERS's ROE of -0.11%. Regarding short-term risk, DCTH is less volatile compared to CERS. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check CERS's competition here
CapsoVision, Inc. (NASDAQ: CV)
DCTH vs CV Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, CV has a market cap of 336M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while CV trades at $6.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas CV's P/E ratio is -10.02. In terms of profitability, DCTH's ROE is +0.00%, compared to CV's ROE of -1.78%. Regarding short-term risk, DCTH is less volatile compared to CV. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check CV's competition here
Orthofix Medical Inc. (NASDAQ: OFIX)
DCTH vs OFIX Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, OFIX has a market cap of 317.9M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while OFIX trades at $7.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas OFIX's P/E ratio is -5.12. In terms of profitability, DCTH's ROE is +0.00%, compared to OFIX's ROE of -0.14%. Regarding short-term risk, DCTH is less volatile compared to OFIX. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check OFIX's competition here
Semler Scientific, Inc. (NASDAQ: SMLR)
DCTH vs SMLR Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, SMLR has a market cap of 310.7M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while SMLR trades at $20.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas SMLR's P/E ratio is 3.92. In terms of profitability, DCTH's ROE is +0.00%, compared to SMLR's ROE of +0.20%. Regarding short-term risk, DCTH is more volatile compared to SMLR. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check SMLR's competition here
ClearPoint Neuro, Inc. (NASDAQ: CLPT)
DCTH vs CLPT Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, CLPT has a market cap of 275.5M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while CLPT trades at $8.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas CLPT's P/E ratio is -7.28. In terms of profitability, DCTH's ROE is +0.00%, compared to CLPT's ROE of -1.70%. Regarding short-term risk, DCTH is less volatile compared to CLPT. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check CLPT's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
DCTH vs INFU Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, INFU has a market cap of 273.5M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while INFU trades at $13.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas INFU's P/E ratio is 33.49. In terms of profitability, DCTH's ROE is +0.00%, compared to INFU's ROE of +0.16%. Regarding short-term risk, DCTH is less volatile compared to INFU. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check INFU's competition here
Profound Medical Corp. (NASDAQ: PROF)
DCTH vs PROF Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, PROF has a market cap of 263.8M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while PROF trades at $7.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas PROF's P/E ratio is -7.37. In terms of profitability, DCTH's ROE is +0.00%, compared to PROF's ROE of -0.28%. Regarding short-term risk, DCTH is less volatile compared to PROF. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check PROF's competition here
Quantum-Si incorporated (NASDAQ: QSI)
DCTH vs QSI Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, QSI has a market cap of 263.6M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while QSI trades at $1.33.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas QSI's P/E ratio is -2.88. In terms of profitability, DCTH's ROE is +0.00%, compared to QSI's ROE of -0.45%. Regarding short-term risk, DCTH is less volatile compared to QSI. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check QSI's competition here
Treace Medical Concepts, Inc. (NASDAQ: TMCI)
DCTH vs TMCI Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, TMCI has a market cap of 262.7M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while TMCI trades at $4.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas TMCI's P/E ratio is -4.30. In terms of profitability, DCTH's ROE is +0.00%, compared to TMCI's ROE of -0.76%. Regarding short-term risk, DCTH is less volatile compared to TMCI. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check TMCI's competition here
Monogram Orthopaedics, Inc. (NASDAQ: MGRM)
DCTH vs MGRM Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, MGRM has a market cap of 243.8M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while MGRM trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas MGRM's P/E ratio is -12.00. In terms of profitability, DCTH's ROE is +0.00%, compared to MGRM's ROE of -1.17%. Regarding short-term risk, DCTH is more volatile compared to MGRM. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check MGRM's competition here
Nevro Corp. (NYSE: NVRO)
DCTH vs NVRO Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, NVRO has a market cap of 224.1M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while NVRO trades at $5.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas NVRO's P/E ratio is -1.91. In terms of profitability, DCTH's ROE is +0.00%, compared to NVRO's ROE of -0.43%. Regarding short-term risk, DCTH is more volatile compared to NVRO. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check NVRO's competition here
Electromed, Inc. (AMEX: ELMD)
DCTH vs ELMD Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, ELMD has a market cap of 223.4M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while ELMD trades at $27.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas ELMD's P/E ratio is 20.58. In terms of profitability, DCTH's ROE is +0.00%, compared to ELMD's ROE of +0.23%. Regarding short-term risk, DCTH is less volatile compared to ELMD. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check ELMD's competition here
TriSalus Life Sciences, Inc. (NASDAQ: TLSI)
DCTH vs TLSI Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, TLSI has a market cap of 199.5M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while TLSI trades at $3.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas TLSI's P/E ratio is -1.93. In terms of profitability, DCTH's ROE is +0.00%, compared to TLSI's ROE of +2.74%. Regarding short-term risk, DCTH is less volatile compared to TLSI. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check TLSI's competition here
BioSig Technologies, Inc. (NASDAQ: BSGM)
DCTH vs BSGM Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, BSGM has a market cap of 191.1M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while BSGM trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas BSGM's P/E ratio is -5.81. In terms of profitability, DCTH's ROE is +0.00%, compared to BSGM's ROE of +6.96%. Regarding short-term risk, DCTH is less volatile compared to BSGM. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check BSGM's competition here
RxSight, Inc. (NASDAQ: RXST)
DCTH vs RXST Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, RXST has a market cap of 188.6M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while RXST trades at $4.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas RXST's P/E ratio is -4.01. In terms of profitability, DCTH's ROE is +0.00%, compared to RXST's ROE of -0.20%. Regarding short-term risk, DCTH is less volatile compared to RXST. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check RXST's competition here
Xylo Technologies Ltd. (NASDAQ: MDGS)
DCTH vs MDGS Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, MDGS has a market cap of 178.9M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while MDGS trades at $2.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas MDGS's P/E ratio is -0.27. In terms of profitability, DCTH's ROE is +0.00%, compared to MDGS's ROE of -0.51%. Regarding short-term risk, DCTH is less volatile compared to MDGS. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check MDGS's competition here
Neuronetics, Inc. (NASDAQ: STIM)
DCTH vs STIM Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, STIM has a market cap of 163.4M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while STIM trades at $2.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas STIM's P/E ratio is -4.87. In terms of profitability, DCTH's ROE is +0.00%, compared to STIM's ROE of -1.28%. Regarding short-term risk, DCTH is less volatile compared to STIM. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check STIM's competition here
Quipt Home Medical Corp. (NASDAQ: QIPT)
DCTH vs QIPT Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, QIPT has a market cap of 162.3M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while QIPT trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas QIPT's P/E ratio is -15.87. In terms of profitability, DCTH's ROE is +0.00%, compared to QIPT's ROE of -0.08%. Regarding short-term risk, DCTH is more volatile compared to QIPT. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check QIPT's competition here
Inogen, Inc. (NASDAQ: INGN)
DCTH vs INGN Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, INGN has a market cap of 160M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while INGN trades at $6.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas INGN's P/E ratio is -6.63. In terms of profitability, DCTH's ROE is +0.00%, compared to INGN's ROE of -0.20%. Regarding short-term risk, DCTH is less volatile compared to INGN. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check INGN's competition here
Quanterix Corporation (NASDAQ: QTRX)
DCTH vs QTRX Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, QTRX has a market cap of 137.1M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while QTRX trades at $2.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas QTRX's P/E ratio is -1.14. In terms of profitability, DCTH's ROE is +0.00%, compared to QTRX's ROE of -0.44%. Regarding short-term risk, DCTH is less volatile compared to QTRX. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check QTRX's competition here
EDAP TMS S.A. American Depositary Shares (NASDAQ: FOCL)
DCTH vs FOCL Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, FOCL has a market cap of 125.9M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while FOCL trades at $3.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas FOCL's P/E ratio is -3.25. In terms of profitability, DCTH's ROE is +0.00%, compared to FOCL's ROE of -2.41%. Regarding short-term risk, DCTH is less volatile compared to FOCL. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check FOCL's competition here
Owlet, Inc. (NYSE: OWLT)
DCTH vs OWLT Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, OWLT has a market cap of 121.6M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while OWLT trades at $4.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas OWLT's P/E ratio is -29.71. In terms of profitability, DCTH's ROE is +0.00%, compared to OWLT's ROE of -0.50%. Regarding short-term risk, DCTH is less volatile compared to OWLT. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check OWLT's competition here
Pulmonx Corporation (NASDAQ: LUNG)
DCTH vs LUNG Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, LUNG has a market cap of 109.9M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while LUNG trades at $2.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas LUNG's P/E ratio is -2.53. In terms of profitability, DCTH's ROE is +0.00%, compared to LUNG's ROE of -0.98%. Regarding short-term risk, DCTH is less volatile compared to LUNG. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check LUNG's competition here
iCAD, Inc. (NASDAQ: ICAD)
DCTH vs ICAD Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, ICAD has a market cap of 106.3M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while ICAD trades at $3.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas ICAD's P/E ratio is -20.37. In terms of profitability, DCTH's ROE is +0.00%, compared to ICAD's ROE of -0.18%. Regarding short-term risk, DCTH is more volatile compared to ICAD. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ICAD's competition here
Hancock Jaffe Laboratories (NASDAQ: HJLI)
DCTH vs HJLI Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, HJLI has a market cap of 98.3M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while HJLI trades at $10.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas HJLI's P/E ratio is N/A. In terms of profitability, DCTH's ROE is +0.00%, compared to HJLI's ROE of -0.70%. Regarding short-term risk, DCTH is less volatile compared to HJLI. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check HJLI's competition here
Perspective Therapeutics, Inc. (AMEX: CATX)
DCTH vs CATX Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, CATX has a market cap of 95.9M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while CATX trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas CATX's P/E ratio is -0.63. In terms of profitability, DCTH's ROE is +0.00%, compared to CATX's ROE of -0.42%. Regarding short-term risk, DCTH is less volatile compared to CATX. This indicates lower risk in terms of short-term price fluctuations for DCTH.Check CATX's competition here
Asensus Surgical, Inc. (AMEX: ASXC)
DCTH vs ASXC Comparison November 2026
Delcath Systems, Inc. (NASDAQ: DCTH) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, DCTH stands at 518.4M. In comparison, ASXC has a market cap of 94.9M. Regarding current trading prices, DCTH is priced at $14.93 on the NASDAQ, while ASXC trades at $0.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
DCTH currently has a P/E ratio of 1494.00, whereas ASXC's P/E ratio is -1.12. In terms of profitability, DCTH's ROE is +0.00%, compared to ASXC's ROE of -1.18%. Regarding short-term risk, DCTH is more volatile compared to ASXC. This indicates higher risk in terms of short-term price fluctuations for DCTH.Check ASXC's competition here